Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to give informed consent to take part in the study
- Adults aged 18 years or older, of any gender
- People who have a confirmed diagnosis of moderate-to-severe Crohn's disease or ulcerative colitis
- People whose doctor has planned for them to start a type of medication called anti-TNF therapy
- People who are able and willing to follow a specific eating plan called the Crohn's Disease Exclusion Diet (CDED)
Who may not be able to join:
- People whose inflammatory bowel disease has not been clearly identified as a specific type
- People who have other metabolic or digestive conditions that could interfere with the study, such as celiac disease or diabetes
- People whose body mass index (BMI) — a measure of body weight relative to height — is below 17 or above 30
- People who have previously had part of their intestine surgically removed, for any reason
- People who are currently on a feeding plan delivered entirely through a tube or liquid formula (called exclusive enteral nutrition)
- People who have previously followed or are currently following the Crohn's Disease Exclusion Diet (CDED)
- Women who are pregnant or breastfeeding
- People with a history of severe allergic reactions or intolerance to any foods included in the CDED eating plan
- People with serious other health conditions that could interfere with the study or create health risks
- People who are unable or unwilling to follow the study's procedures or attend required follow-up appointments
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tommaso Lorenzo Parigi, MD, IRCCS Ospedale San Raffaele
Phone: +39 02 2643 2756
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of CDED in addition to anti-TNF therapy in active CD and UC versus anti-TNF therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.